+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Systemic immune-inflammation index (Sii) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma



Systemic immune-inflammation index (Sii) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma



Journal of Cancer 10(14): 3188-3196




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068515032

Download citation: RISBibTeXText

DOI: 10.7150/jca.30281


Related references

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer. Thoracic Cancer 2019, 2019

A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology 143(10): 2077-2086, 2017

The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Journal of Cellular Physiology 234(2): 1794-1802, 2018

Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria. Cellular Physiology and Biochemistry 47(1): 293-301, 2018

A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. International Immunopharmacology 65: 503-510, 2018

Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients. Annals of Thoracic Surgery 80(3): 1007-1016, 2005

Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma. Bmc Surgery 13: 15, 2013

Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget 6(40): 43090-8, 2016

Systemic Immune-Inflammation Index and Circulating T-Cell Immune Index Predict Outcomes in High-Risk Acral Melanoma Patients Treated with High-Dose Interferon. Translational Oncology 10(5): 719-725, 2017

MIB-1 index is unlikely to predict relapse-free survival in patients who underwent R0-esophagectomy for esophageal squamous cell carcinoma. Diseases of the Esophagus 31(5), 2017

The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma. Clinical and Translational Oncology 19(6): 742-749, 2017

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine 96(4): E5886, 2017

Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma. Journal of Surgical Oncology 113(4): 381-389, 2016

Preoperative systemic immune-inflammation index predicts prognosis of patients with oral squamous cell carcinoma after curative resection. Journal of Translational Medicine 16(1): 365-365, 2018

Is the prognostic impact of tumor location in patients with surgically resected esophageal squamous cell carcinoma affected by surgical approach?. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 51(1-2): 91-98, 2014